Related Experiment Video
Updated: Aug 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Multi-view graph convolutional network for cancer cell-specific synthetic lethality prediction
Kunjie Fan1, Shan Tang2, Birkan Gökbağ1
1Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.
Abstract:
Synthetic lethal (SL) genetic interactions have been regarded as a promising focus for investigating potential targeted therapeutics to tackle cancer. However, the costly investment of time and labor associated with wet-lab experimental screenings to discover potential SL relationships motivates the development of computational methods. Although graph neural network (GNN) models have performed well in the prediction of SL gene pairs, existing GNN-based models are not designed for predicting cancer cell-specific SL interactions that are more relevant to experimental validation in vitro. Besides, neither have existing methods fully utilized diverse graph representations of biological features to improve prediction performance. In this work, we propose MVGCN-iSL, a novel multi-view graph convolutional network (GCN) model to predict cancer cell-specific SL gene pairs, by incorporating five biological graph features and multi-omics data. Max pooling operation is applied to integrate five graph-specific representations obtained from GCN models. Afterwards, a deep neural network (DNN) model serves as the prediction module to predict the SL interactions in individual cancer cells (iSL). Extensive experiments have validated the model's successful integration of the multiple graph features and state-of-the-art performance in the prediction of potential SL gene pairs as well as generalization ability to novel genes.
Insights
This study introduces MVGCN-iSL, a new computational model for identifying cancer-specific synthetic lethal (SL) gene pairs. It improves targeted cancer therapy research by predicting SL interactions more accurately using multi-omics data.
Area of Science:
- Computational biology
- Genomics
- Bioinformatics
Background:
- Synthetic lethal (SL) interactions are crucial for developing targeted cancer therapies.
- Wet-lab screening for SL gene pairs is time-consuming and expensive.
- Existing computational methods, including graph neural networks (GNNs), often lack cancer cell specificity and fail to fully leverage diverse biological features.
Purpose of the Study:
- To develop a novel computational method for predicting cancer cell-specific SL gene pairs.
- To improve the accuracy and efficiency of identifying potential therapeutic targets for cancer.
Main Methods:
- Proposed MVGCN-iSL, a multi-view graph convolutional network (GCN) model.
- Integrated five biological graph features and multi-omics data.
- Utilized max pooling for integrating GCN representations and a deep neural network (DNN) for prediction of cancer cell-specific SL interactions (iSL).
Main Results:
- MVGCN-iSL successfully integrated multiple graph features and multi-omics data.
- The model achieved state-of-the-art performance in predicting SL gene pairs.
- Demonstrated strong generalization ability to novel genes.
Conclusions:
- MVGCN-iSL offers a powerful computational approach for discovering cancer cell-specific SL interactions.
- The model enhances the potential for developing targeted cancer therapeutics.
- Highlights the importance of integrating diverse biological features for improved predictive accuracy.
More Related Videos
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

